Lipid-lowering fibrates extend C-elegans lifespan in a NHR-49/PPARalpha-dependent manner
OPEN ACCESS
Loading...
Author / Producer
Date
2013-04
Publication Type
Journal Article
ETH Bibliography
yes
Citations
Altmetric
OPEN ACCESS
Data
Rights / License
Abstract
Compounds that delay aging in model organisms may be of significant interest to anti-aging medicine, since these substances potentially provide pharmaceutical approaches to promote healthy lifespan in humans. We here aimed to test whether pharmaceutical concentrations of three fibrates, pharmacologically established serum lipid-lowering drugs and ligands of the nuclear receptor PPARalpha in mammals, are capable of extending lifespan in a nematodal model organism for aging processes, the roundworm Caenorhabditis elegans.
Adult C. elegans (wild-type N2 as well as two nhr-49-deficient strains, RB1716 and VC870) were maintained on agar plates and were fed E. coli strain OP50 bacteria. Bezafibrate, clofibrate, and fenofibrate were applied to the agar, respectively, to test whether they may promote longevity by quantifying survival in the presence and absence of the respective compounds.
All three fibrates extended C. elegans N2 lifespan when applied at a concentration of 10 micromolar. Bezafibrate additionally extended C. elegans N2 lifespan at concentrations of 1 micromolar and 0.1 micromolar. In strains deficient for nhr-49, a functional orthologue of the mammalian peroxisome proliferator-activated receptor alpha (PPARalpha), all three compounds were incapable of extending lifespan.
Taken together, fibrates promote C. elegans longevity in an NHR-49-dependent manner possibly by promoting mitohormesis and suggesting that these compounds may promote lifespan also in mammals.
Permanent link
Publication status
published
External links
Editor
Book title
Journal / series
Volume
5 (4)
Pages / Article No.
270 - 275
Publisher
PubMed Central
Event
Edition / version
Methods
Software
Geographic location
Date collected
Date created
Subject
ageing; lifespan; healthspan; C. elegans; nematodes; pharmacology; nuclear receptors; peroxisomes; peroxisome proliferator activated receptor alpha; PPARalpha; beta oxidation
Organisational unit
03976 - Ristow, Michael (ehemalig) / Ristow, Michael (former)